Valeant Fires Back After Allergan Calls Offer "Grossly Inadequate" – ValueWalk Premium
valeant pharmaceuticals

Valeant Fires Back After Allergan Calls Offer "Grossly Inadequate"

The heat in the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) unsolicited takeover offer for Allergan, Inc. (NYSE:AGN) is getting hotter, with Allergan advising their investors to reject Valeant’s “grossly inadequate” offer. Valeant fired back this morning in a press release refuting Allergan’s "misleading assertions."

Allergan, Inc. (NYSE:AGN)’s board said the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) offer should be rejected because it undervalues . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0